Validation of the prognostic value of the genes constituting the 3-gene and 5-gene expression profiles with respect to histopathological types of NSCLC

Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska A, Rzepko R, Taron M, Rosell R, Gajewski M, Rzyman W, Jassem J.
European Respiratory Journal (in press)

mRNA expression levels and genetic status of genes involved in the EGFR and NF-_B pathways in metastatic non-small-cell lung cancer patients

Santarpia M, Magri I, Sanchez-Ronco M, Costa C, Molina-Vila M. A, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Benlloch S, Viteri, Gasco A, Mederos N, Carcereny E, Taron M, Rosell R.
Journal of Translational Medicine 2011, 9:163

Pre-treatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations.

Rosell R, Molina M. A, Costa C, Simonetti S, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Moran T, Mendez P, Cardenal F, Isla D, Provencio M, Cobo M, Insa A, Garcia-Campelo R, Reguart N, Majem M, Viteri S, Carcereny E, Porta E, Massuti B, Queralt C, de Aguirre I, Sanchez J. M, Sanchez-Ronco M, Mate J. L, Ariza A, Benlloch S, Sanchez J. J, Bivona T, Sawyers C, Taron M.
Clin Cancer Research 2011;17:1160-1168

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Wu X, Ye Y, Rosell R, Amos C. A, Stewart D, Hildebrandt M, Roth J, Minna J, Gu J, Lin J, Buch S, Nukui T, Ramirez Serrano J. L, Taron M, Cassidy A, Lu C, Chang J, Lippman S, Hong W. K, Spitz M, Romkes M, Yang P.
J Nat Cancer Inst 2011 103;10 817-825

mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer.

Wei J, Costa C, Ding Y, Zou Z, Yu L, Sanchez JJ, Qian X, Chen H, Gimenez-Capitan A, Meng F, Moran T, Benlloch S, Taron M, Rosell R, Liu B.
J Natl Cancer Inst. 2011 103; 20 1552-1556